COVID-19: Delay of third jab for extremely vulnerable

Studies have shown that people who are immunosuppressed – around 500,000 people in the UK – are unlikely to mount a strong defence against COVID-19, even after two doses of vaccine: UK vaccine booster scheme likely to start in September Do I need a booster? On 1 September, the Joint Committee on Vaccination and Immunisation […]

read more

ESMO 2021: Cancer and COVID-19: Outcomes and risk factors

This year there was some very important data presented at the ESMO 2021 virtual meeting regarding COVID-19 and cancer. We have been dealing with this pandemic for a long time, and researchers have been working hard to generate data that can inform clinical decisions regarding the outcomes and risk factors in patients with cancer and […]

read more

ESMO 2021: COVID-19 vaccine in cancer patients is comparable to the general population

The latest findings from five studies presented at the ESMO Congress 2021 help cut short the debate on the safety and efficacy of COVID vaccines in cancer patients and re-affirm ESMO’s recommendations for early vaccination of this high-priority population, as outlined in the ESMO ten statements, which were updated in April 2021. Patients with cancer or a history […]

read more

Immunotherapy and COVID-19 in cancer patients

A recent review published in the Journal for ImmunoTherapy of Cancer looks at the implications of people with renal cell carcinoma (RCC) taking immune checkpoint inhibitors and contracting the SARS-CoV-2 virus. Cancer patients are considered at high risk during the coronavirus pandemic. However, this review states that, although additional studies are needed, the most up-to-date […]

read more

Most vulnerable people could be offered a COVID vaccine booster in September

The Joint Committee on Vaccination and immunisation (JVCI) have given interim advice on who to prioritise for a third dose of the COVID-19 booster vaccine from September. Millions of the most vulnerable people to COVID-19 may be offered the booster vaccination to ensure they have protection through the winter against new coronavirus variants. The JVCI’s […]

read more
Showing all 5 results